| Patents for C07C 65 - Compounds having carboxyl groups bound to carbon atoms of six-membered aromatic rings and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (5,447) |
|---|
| 11/21/2001 | EP0952974B1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same |
| 11/21/2001 | CN1323203A FC receptor modulators and uses thereof |
| 11/20/2001 | US6320074 In vivo modulation of lipid metabolism, skin-related processes, autoimmune diseases, fatty acid metabolism, malignant cell development, premalignant lesions, or programmed cell death |
| 11/13/2001 | US6316404 Treatment of non-insulin-dependent diabetes mellitus using an rxr agonist alone or in combination with a ppar.gamma. agonist such as a thiazolidinedione compound. |
| 11/13/2001 | US6316009 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharamaceutical and cosmetic compositions containing same |
| 11/08/2001 | WO2001083438A2 New gamma selective retinoids |
| 11/08/2001 | CA2407189A1 New gamma selective retinoids |
| 11/07/2001 | EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 11/06/2001 | US6313162 Propynyl or dienyl biaromatic compounds |
| 11/06/2001 | US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 11/06/2001 | CA1341314C Derivatives of benzimidazole, benzothiazole and benzoxazole |
| 11/01/2001 | WO2001030736A3 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors |
| 11/01/2001 | US20010037025 Benzopyran, benzothiopyran or benzoquinone derivatives are useful in the treatment of ailments and disorders where a reduction of blood glucose is benefical, such as diabetes |
| 10/31/2001 | CN1319584A Process for preparing 3,5-di-tert-butyl salicylic acid |
| 10/25/2001 | US20010034448 New compounds, their preparation and use |
| 10/24/2001 | CN1319083A 5,6-Dihydronaphthalenyl derivatives haivng retionoid-like activity |
| 10/23/2001 | CA2054143C Salicylic acid derivatives |
| 10/17/2001 | CN1073081C Naphthol derivatives and process for producing same |
| 10/16/2001 | US6303785 Substituted n-cyclopropyltetrahydroisoquinolines |
| 10/11/2001 | WO2001074753A1 Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof |
| 10/11/2001 | DE10015525A1 Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung Synthetic derivatives of Lunularsäure, to medicaments containing this compound, methods of making them and their use of the Lunularsäurederivate |
| 10/10/2001 | EP1142861A1 Granules of 2-hydroxynaphthalene-3-carboxylic acid and method for preparing the same |
| 10/10/2001 | CN1316986A Novel compounds |
| 10/10/2001 | CN1316985A Crystal of z-hydroxynaphthalene-3-carboxylic acid and process for preparation thereof |
| 10/09/2001 | US6300376 Indane dimer compounds and their pharmaceutical use |
| 10/02/2001 | US6297399 Hypotensive agents |
| 09/27/2001 | WO2001070663A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 09/27/2001 | CA2403553A1 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 09/26/2001 | EP0846146B1 Colorant stabilizing composition |
| 09/26/2001 | CN1314437A Raw material compound and its producing method |
| 09/26/2001 | CN1314337A Method for producing 3,4,5 trimethoxybenzoic acid |
| 09/26/2001 | CN1071738C Carboxylic derivatives exhibiting phospholipase A2 inhibitory activity |
| 09/20/2001 | US20010023300 Preparing by reacting 3-cyano-2,4-dichloro-4-fluoro-benzoyl chloride nucleophilically with a fluoridizing agent; forming 3-cyano-2,4,5-trifluoro-benzoyl chloride from title compound; intermediates to antiinfective quinolonecarboxylic acids |
| 09/19/2001 | EP0686181B1 Fuel compositions containing substituted poly(oxyalkylene) aromatic ethers |
| 09/19/2001 | EP0649417B1 Improved chemiluminescent 1,2-dioxetanes |
| 09/18/2001 | US6291689 Cyclizing 4-cyano-2-hydroxymethylphenyl)(4-fluorophenyl)methanol to form 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile; alkylating to form citalopram |
| 09/18/2001 | US6291677 Compounds having activity as inhibitors of cytochrome P450RAI |
| 09/18/2001 | CA1341294C Intermediates for preparing 4-oxyquinoline-3-carboxylic acid derivatives |
| 09/12/2001 | EP1132119A2 Method for concealing information and document for securely communicating concealed information |
| 09/12/2001 | EP1131277A1 Method of modifying components present in cashew nut shell liquid |
| 09/12/2001 | EP0772580B1 Benzoyl derivatives and synthesis thereof |
| 09/11/2001 | US6288271 Process for the preparation of (2,2,2-trifluoroethoxy)benzoic acids |
| 09/11/2001 | US6288260 Process for making 2-alkyl-3-hydroxybenzoic acids |
| 09/11/2001 | US6288247 Catalytic multistage process forming a racemic mixture of compounds |
| 09/11/2001 | US6288092 Triaryl compounds |
| 09/05/2001 | EP1129707A2 Methods for identifying and treating resistant tumors |
| 09/05/2001 | CN1311767A Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 09/05/2001 | CN1070470C Method for purificatino of 2-hydroxynaphthalene-6-carboxylic acid |
| 09/04/2001 | US6284924 Bis/oxynaphthalene derivatives of carboxylic acids |
| 09/04/2001 | CA2021550C Novel tritium marqued compounds, its preparation and application for finding of retinoid nuclear receptors |
| 08/29/2001 | EP1127869A1 Novel compounds and medicinal use thereof |
| 08/29/2001 | EP0809622B1 Anti-inflammatory benzoic acid derivatives |
| 08/22/2001 | EP1125907A2 Intermediates for the production of citalopram |
| 08/21/2001 | CA2207607C Photo-erasable data processing forms |
| 08/21/2001 | CA2030792C Perfluorovinyl compounds |
| 08/17/2001 | CA2318701A1 Production method of citalopram, intermediate therefor and production method of the intermediate |
| 08/16/2001 | EP1123938A2 Organometallic fluorenyl compounds, preparation, and use |
| 08/16/2001 | EP1123814A2 Method and apparatus for indicating ultraviolet light exposure |
| 08/16/2001 | EP1123813A2 Instrument for photoerasable marking |
| 08/16/2001 | EP1123812A2 Article for colored printing and method for printing |
| 08/16/2001 | EP1123811A2 Photoerasable paint and method for using photoerasable paint |
| 08/16/2001 | EP1123266A1 Method for drying phenoxymethylbenzoic acids |
| 08/16/2001 | EP0830676B1 Digital information recording media and method of using same |
| 08/15/2001 | CN1308598A Process for the isolation of aromatic hydroxycarboxylic acids |
| 08/15/2001 | CN1308492A Hypericin and i(hypericum) extract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeutics |
| 08/14/2001 | US6274776 Oxidation process |
| 08/09/2001 | WO2001056968A1 Calixarenes and their use as lubricant additives |
| 08/09/2001 | WO2001032596A8 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 08/02/2001 | WO2001055085A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity |
| 08/02/2001 | CA2395298A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity |
| 08/01/2001 | EP1120423A1 Improved chemiluminescent 1,2-dioxetanes |
| 08/01/2001 | EP1120422A1 Improved chemiluminescent 1,2-dioxetanes |
| 08/01/2001 | CN1305985A Process for preparing intermediate of Xidinafei |
| 07/26/2001 | US20010009923 Salt with pamoic acid, used in treatment of myocardial ischemia, angina pectoris, heart failure and arrhythmias; muscular asthenia and cramps; as food supplement, dietetic |
| 07/18/2001 | EP1116708A1 A method of dehydrating a tertiary alcohol |
| 07/18/2001 | EP1115687A1 5,6-dihydronaphthalenyl derivatives having retinoid-like activity |
| 07/17/2001 | US6261731 Containing as charge control agent a trivalent chromium salt of salicylic acid/derivatives prepared by adding solution of alkali metal salt of salicylic acid/derivatives to chromium (iii) halide; electrophotography, electrostatics |
| 07/10/2001 | US6258843 4-oxy-3-(aryl)phenyl-arylcarbonyloxy compounds useful as phosphodiesterase inhibitors |
| 07/10/2001 | CA2175643C Utilization of retinoids in a cosmetic composition or in the preparation of a pharmaceutical composition |
| 07/05/2001 | US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture |
| 07/03/2001 | US6255326 Antiinflammatory agent; autoimmune diseases |
| 07/03/2001 | US6255298 Using an aromatic amide compound |
| 06/28/2001 | WO2001046130A1 Process for the preparation of diphenyl ether compounds |
| 06/28/2001 | WO2000001653A9 A process for the isolation of aromatic hydroxycarboxylic acids |
| 06/27/2001 | EP1109545A1 Fc RECEPTOR MODULATORS AND USES THEREOF |
| 06/26/2001 | US6252104 3,6-disubstituted-2-oxynaphthalene derivatives; raw materials for synthesis of such materials as dyes, pigments, photosensitive materials |
| 06/26/2001 | US6252090 Compounds having activity as inhibitors of cytochrome P450RAI |
| 06/26/2001 | US6251898 Medical use of fluorenone derivatives for treating and preventing brain and spinal injury |
| 06/21/2001 | WO2001044155A1 Cyclic compound |
| 06/12/2001 | US6245936 Process for the selective preparation of a 2-hydroxybenzoic acid and a 4-hydroxybenzaldehyde and derivatives thereof |
| 06/06/2001 | CN1066746C Aromatic hydroxycarboxylic acid resins and their use |
| 05/31/2001 | WO1999024394A9 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 05/30/2001 | EP1102739A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 05/30/2001 | CN1296940A Environmentally friendly process for preparing benzoic acid and its derivatives |
| 05/30/2001 | CN1066452C Crystalline cephem acid addition salts and processes for their preparation |
| 05/25/2001 | WO2001036351A2 Plasminogen activator inhibitor antagonists related applications |
| 05/23/2001 | EP1100763A1 Diketoacid-derivatives as inhibitors of polymerases |
| 05/23/2001 | EP0986533A4 Identification of a unique receptor specific for a particular retinoid inducing cellular apoptosis |
| 05/23/2001 | CN1296024A Partial esterification products of aromatic hydroxy-carboxylic resin and use thereof |
| 05/22/2001 | US6235923 Retinoids and cell differentiation |